Pharming Group (PHAR)
(Delayed Data from NSDQ)
$8.91 USD
+0.05 (0.56%)
Updated Oct 31, 2024 03:51 PM ET
After-Market: $8.57 -0.34 (-3.82%) 7:48 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
PHAR 8.91 +0.05(0.56%)
Will PHAR be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for PHAR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PHAR
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
PHAR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PHAR
Pharos Energy Announces Voting Rights Update
Pharos Energy Enhances Shareholder Value with Buyback
Pharos Energy Enhances Shareholder Value with Buyback
Pharos Energy Leaders Invest in Company Shares
Pharos Energy Sees Major Shareholding Shift